查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1854514

新冠病毒即時檢測試劑套件市場：按產品類型、應用、檢測技術、樣本類型、最終用戶和分銷管道分類－全球預測，2025-2032年

COVID-19 Detection PoC Kits Market by Product Type, Application, Detection Technology, Sample Type, End User, Distribution Channel - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 190 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，COVID-19 檢測即時檢驗試劑套件市場規模將達到 61.8 億美元，複合年成長率為 6.95%。

主要市場統計數據
基準年 2024 36.1億美元
預計年份：2025年 38.6億美元
預測年份：2032年 61.8億美元
複合年成長率 (%) 6.95%

權威的介紹文章，闡述了疫情時代快速的技術創新如何發展成為臨床和分散式環境中複雜、永續的診斷生態系統。

新冠病毒檢測概念驗證（PoC）套件的格局已從緊急應變演變為診斷韌性中一個細緻入微且持續發揮作用的組成部分。在疫情初期，快速檢測開發和緊急使用授權優先考慮的是速度而非規模，而隨後的幾年則更加注重穩健性、持續供應以及與臨床工作流程的整合。這種演進催生了一個產業生態系統，其中包含各種耗材、儀器和套件，適用於從集中式實驗室到分散式照護現場不同情境。

隨著公共衛生工作的重點轉向地方性疾病管理，臨床檢測、監測、自測和監測應用領域的相關人員正在尋求兼顧靈敏度、易用性和成本效益的解決方案。抗體、抗原和環介導等溫擴增 (LAMP) 檢測等檢測技術，目前不僅要評估其分析性能，還要評估其可生產性、分銷物流和監管穩定性。同時，鼻咽拭子、口咽拭子和唾液等檢體採集方法也在推動套件設計和使用說明的迭代改進，以減少變異性，並使其能夠在診斷中心、居家照護機構和醫院環境中得到廣泛應用。

引言部分首先從製造商、經銷商、臨床應用者和公共衛生機構的營運實際情況出發，闡述了這些動態，為後續的深入分析奠定了基礎：即需要超越應急部署模式，轉向永續且可擴展的業務和供應鏈實踐，同時保持對流行病學變化的快速應對力。在此基礎上，後續章節詳細闡述了轉型轉變、政策影響、細分市場的細微差別、區域模式、競爭行為、可操作的建議以及支撐本文觀點的調查方法。

再形成診斷工作流程、供應鏈韌性和技術整合的關鍵結構性轉變進行策略分析，這將重新定義概念驗證測試。

即時檢測 (PoC) 試劑套件的市場格局正受到多項變革性變化的再形成，這些變化正在重新定義相關人員制定檢測策略和產品開發的方式。首先，診斷工作流程的去中心化迫在眉睫。醫療系統和私人醫療機構越來越傾向於選擇能夠在傳統實驗室之外提供可靠結果的 PoC 解決方案，這促使製造商優先考慮以用戶為中心的設計、簡化的樣本採集流程以及與數位化報告平台的整合。隨著時間的推移，監管機構也在調整這些去中心化工具的部署管道，這不僅加快了其普及速度，也提高了對上市後監管和實際應用效能證據的期望。

其次，供應鏈韌性已成為策略關鍵。疫情暴露了試劑、拭子和電子檢測模組等關鍵組件對單一來源的依賴性，促使企業投資於多元化採購、區域製造能力和庫存策略，以緩衝供應中斷。第三，科技融合正在加速。側向流動免疫檢測、抗原檢測、抗體血清學和基於LAMP的核酸擴增方法等技術正被設計成具有互補優勢，以滿足不同的臨床和監測需求。這種技術的多樣性使得診斷管道更加個人化，但也使採購變得更加複雜，並需要新的比較評估框架。

第四，資料整合和互通性日益凸顯。當檢測結果能夠輕鬆導入電子健康記錄、人群健康儀錶板和患者導向的應用程式時，即時檢測 (PoC) 的效用將會大大提升。因此，軟體和數位基礎設施的夥伴關係如今已成為產品價值提案不可或缺的一部分。最後，商業模式正從直接銷售多元化發展，涵蓋試劑補充訂閱服務、儀器訪問平台即服務 (PaaS) 以及將檢測套組與遠端醫療和護理導航相結合的捆綁式解決方案。這種轉變正將即時檢測試劑套件從孤立的耗材轉變為更廣泛的臨床、物流和數位生態系統中的節點。

對關稅主導的貿易動態如何重塑診斷供應鏈的採購、製造本地化和成本結構進行嚴謹評估

提高關稅將對新冠病毒檢測即時檢驗試劑套件的價值鏈產生連鎖反應，影響原料、成品和跨境分銷策略。關稅將改變耗材和設備的到岸成本，迫使製造商和採購團隊重新評估其籌資策略和庫存計畫。對於依賴海外生產的專用零件的製造商而言，關稅可能會促使其將生產外包到近岸地區，並與其他供應商建立合作關係。

從商業性角度來看，進口成本上升將擠壓供應商的利潤空間，除非下游環節的價格調整能夠抵銷這種影響。醫院和診斷中心等買家面臨著成本控制與確保穩定供應之間的兩難困境，這促使一些機構整合供應商或協商長期契約，以穩定單價和交貨時間。醫院藥局、線上藥局和零售藥局等分銷管道可能會重新調整庫存管理和訂購週期，以降低成本波動並維持服務的連續性。

針對關稅制度的政策因應措施也會影響市場行為。政府有時會將關稅與國內製造業獎勵結合，提供補貼和稅收優惠以加速本地產能的提升。此類獎勵可能造成市場兩極化，即小眾的專業試劑繼續依賴進口，而大規模生產的標準化產品則在國內生產。企業決策越來越重視供應鏈的適應性和合規性，而策略規劃必須納入考慮關稅造成的成本差異及其對採購、定價和市場進入的影響等因素。

從整合的、以細分市場主導的觀點，可以揭示產品設計、監管證據和分銷策略之間的交匯點，從而最大限度地提高產品採納率和臨床效用。

細分市場分析為理解PoC試劑套件領域中創新、應用和機會的交匯點提供了一個框架。透過分析產品類型（耗材、儀器、套件），我們可以發現營運和商業方面的考慮：耗材需要大批量、可重複的供應和嚴格的品管；儀器需要資本支出論證和生命週期支援；而試劑套件則將試劑和說明書以針對特定使用環境最佳化的形式組合在一起。每個類別都對應著不同的採購週期和支援需求，這反過來又會影響供應商的打入市場策略。

基於應用場景的細分，例如臨床檢測、研究、自我檢測和監測，突顯了不同應用場景在效能要求和使用者體驗方面的差異。臨床檢測優先考慮檢驗的靈敏度和與臨床工作流程的整合；研究強調靈活性和檢測方法的客製化；自我檢測要求操作簡便，並提供清晰的用戶指導，以確保即使在非專業環境下也能保持準確性；而監測系統則優先考慮人群監測的通量和成本效益。這些應用場景的差異會影響偵測技術的定位和檢驗方式。

將抗體、抗原和LAMP檢測技術細分，可以發現它們不同的應用場景和檢驗途徑。抗體檢測能夠提供有關血清陽性率和既往感染史的有用資訊；抗原檢測針對快速檢測活動性感染進行了最佳化，兼顧了速度和靈敏度；而基於LAMP的方法因其便攜的核酸擴增方式，避免了傳統PCR的複雜性，因此在分散式環境中極具吸引力。樣本類型（鼻咽拭子、口咽拭子或唾液）會影響使用者體驗、生物安全考量和分析靈敏度，而樣本類型的選擇也會影響套件的設計和使用說明。

將終端使用者細分為診斷中心、居家醫療和醫院，可以發現他們對採購模式和技術支援的不同期望。診斷中心通常需要批量檢測的高通量和檢驗的檢測方法的可比性，而居家照護優先考慮易用性和清晰的解讀，醫院則需要能夠可靠地整合到住院護理流程中的解決方案。將分銷管道細分——包括醫院藥房、線上藥房和零售藥房——可以反映出獲取便利性和患者行為。線上管道擴大了覆蓋範圍並提高了便利性，但也引發了關於正確儲存和指導方面的問題。整合這些細分訊息，可以揭示產品開發應在哪些方面進行改進，例如可用性、監管證據、供應計劃和數位化整合，以滿足每個相關利益者群體的獨特需求。

細緻入微的區域一體化表明，法律規範、製造能力和醫療保健服務模式如何影響即時診斷解決方案的採用。

區域動態將顯著影響即時診斷產品的研發、監管和部署。在美洲，法律規範各異，但擁有先進的私人醫療網路和強大的購買力，加速了先進照護現場設備的普及，同時也催生了對價格適中的自測和監測工具的需求。該地區龐大的國內製造業基礎可用於緩解供應鏈中斷，但都市區之間的醫療資源取得差異依然存在，因此需要採取差異化的分銷策略。

在歐洲、中東和非洲，監管協調工作和聯合公共衛生舉措正在推動對可跨多個醫療系統擴展的互通性檢測解決方案的需求。該地區的監測基礎設施正在迅速擴展，既有高通量集中式檢測機構，也有新興的分散式檢查項目。各地的採購政策和報銷模式各不相同，這影響著哪些技術能夠佔據主導地位，以及供應商如何建構其市場准入和夥伴關係策略。

亞太地區擁有多元化的生態系統，涵蓋了從高產能製造地到快速發展的區域檢測項目。多個國家擁有強大的製造業生態系統，既支持國內供應，也支持出口導向生產，監管機構在核准創新診斷管道方面也展現出靈活性。雖然都市區正在加速採用自測模式和醫療服務數位化整合，但農村和偏遠地區仍需要能夠滿足資源匱乏需求的可靠解決方案。在所有地區，跨境合作、官民合作關係以及對本地製造能力的定向投資將影響即時診斷（PoC）的可用性和永續性，而區域優先事項將指導所部署的技術組合、樣本採集方式和配銷通路。

本文基於實證檢驗了策略夥伴關係、平台模組化和整體解決方案如何重新定義診斷開發領域的競爭優勢。

在即時檢測（PoC）領域，企業間的競爭以產品快速迭代、策略夥伴關係和靈活的商業模式為特徵。製造商正日益推行模組化平台策略，以便快速重新配置檢測方法和試劑，從而應對病原體生物學和市場需求的變化。與試劑供應商、契約製造和軟體整合商建立策略夥伴關係，已成為加快產品上市速度和拓展銷售能力的關鍵。

診斷技術開發商與醫療服務提供者之間的合作也日益普遍，早期臨床檢驗和反饋循環有助於迭代改進設計。許可和合資企業能夠幫助企業在不承擔生產風險的情況下拓展地域範圍，而與大型醫療機構簽訂的供應協議則有助於穩定市場需求。同時，規模較小的創新企業正透過專注於特定應用或獨特的檢測化學技術來實現產品差異化，並常常著眼於與大型公司進行收購或合作開發。

商業性差異化越來越依賴整體解決方案，包括檢測性能和儀器維護性、試劑物流、用戶培訓以及數位化結果管理。投資於售後支援、為非實驗室使用者提供清晰易懂的培訓材料以及收集真實世界證據的公司，將有助於提升產品的長期應用率。整體而言，競爭格局青睞那些敏捷性、深度夥伴關係關係以及能夠在各種醫療保健環境中提供高效、易用解決方案的公司。

為領導者提供建立彈性供應鏈、加強以用戶為中心的設計以及使商業模式與不斷變化的醫療保健需求相適應的實用策略

為了因應即時診斷（PoC）需求的變化，產業領導者應採取多管齊下的策略，優先考慮供應鏈韌性、以使用者為中心的設計和策略性商業化。首先，透過供應鏈多元化、尋找替代供應商、實現關鍵試劑和組件的雙重採購以及投資區域製造能力，降低對單一供應商的依賴。這將有助於減少貿易中斷和關稅波動帶來的風險，同時支持對局部需求高峰的快速反應。

其次，我們將著重提升產品在不同終端使用者中的易用性，簡化檢體流程，提供全面的非專業人員操作指南，並加入安全保障措施以減少使用者操作失誤。優先開發相容檢體、口咽拭子和檢體的格式，檢體拓寬產品應用場景，提高使用者接受度。第三，加強數位整合，確保與臨床記錄和公共衛生系統無縫對接，將增強產品對醫療採購方的價值提案，並支持監測目標的實現。

第四，採用靈活的商業模式，包括試劑補充訂閱和儀器即服務，以降低小型機構採用這些技術的門檻。第五，積極與監管機構和支付方合作，制定循證方案，以證明其在特定用途（例如臨床檢測、研究、自我檢測和監測）中的實際有效性。最後，與包括醫院藥房、線上藥房和零售藥房在內的分銷管道建立夥伴關係，以協調庫存管理、培訓和供應透明度。這些合作措施將使各機構能夠提供滿足臨床和公共衛生需求的、具彈性和可擴展性的解決方案。

我們透明的調查方法結合了對主要相關人員的訪談和嚴格的二次檢驗，從而提供符合倫理、可操作的見解，而無需進行定量市場預測。

這些調查方法結合了結構化的初步研究和系統的二次分析，以確保研究結果的可靠性和檢驗。初步研究包括對價值鏈上各相關人員（產品開發人員、採購負責人、分銷合作夥伴和監管顧問）進行半結構化訪談，以了解營運實務、產品推廣促進因素和未滿足的需求。這些訪談旨在挖掘影響採購和部署選擇的實際決策標準和現實限制因素。

二次分析整合了監管指南、同行評審文獻、技術白皮書和公開政策文件，以闡明技術性能特徵和當地法規環境。採用資料三角驗證法，利用多資訊來源檢驗定性分析結果，以減少偏差並提高可靠性。在適當情況下，進行情境分析，評估關稅調整或供應中斷等變化將如何影響策略決策。

本研究的局限性包括流行病學形勢的快速變化以及可能導致優先事項改變的新技術創新。因此，我們的研究結果著重於持久的策略考量和以流程為導向的建議。在初步研究中，我們考慮了倫理因素，包括對所有權資訊進行匿名化處理並獲得參與者的知情同意。調查方法反映了在深入的定性見解和廣泛的二手證據之間取得務實平衡，旨在為即時診斷（PoC）生態系統中的相關人員提供切實可行的指導。

簡潔扼要的結論，整合了技術、供應鏈韌性和用戶獲取方面的策略要務，為永續決策提供資訊。

根據這份簡報，新冠病毒即時檢測（PoC）領域已發展成為一個複雜的生態系統，其中技術、供應鏈、監管和用戶體驗相互作用，共同決定商業性和公共衛生結果。重點正從快速部署轉向永續和具有韌性的模式，以支援分散式檢測、強力的監測以及與醫療服務體系的整合。從產品類型、應用、檢測技術、樣本類型、最終用戶和分銷管道等多個維度進行細分，可以發現創新和策略投資的精準機會。

區域動態和政策槓桿，包括貿易措施和本地生產獎勵，將繼續影響解決方案的生產和分銷地點及方式。將模組化產品平台、策略夥伴關係和全面的服務產品與清晰的實際性能證據相結合的企業將獲得競爭優勢。最終，最成功的策略是將卓越的技術與供應鏈彈性、用戶可近性和監管參與等實際因素相結合，以確保診斷工具能夠同時服務臨床護理和公共衛生。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 將基於 CRISPR 的診斷技術整合到可攜式即時檢測設備中，以加快 COVID-19 檢測速度。
  • 採用能同時檢測多種呼吸道病原體的多重免疫檢測分析側向層析檢測方法
  • 在照護端實施整合智慧型手機的呼吸分析感測器，用於無創新冠病毒篩檢
  • 在家自行採集抗原檢測套件的使用量激增，遠端醫療指導有助於準確診斷新冠病毒感染。
  • 將人工智慧驅動的影像分析整合到可攜式RT-PCR平台中，以增強結果解讀和報告。

第6章美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. COVID-19 檢測即時檢驗試劑套件市場（依產品類型分類）

  • 消耗品
  • 裝置
  • 套件

9. 依應用分類的 COVID-19 檢測即時檢驗試劑套件市場

  • 實驗室測試
  • 研究
  • 自測
  • 監測

10. 依檢測技術分類的 COVID-19 即時檢測試劑套件市場

  • 抗體
  • 抗原
  • LAMP

11. 依樣本類型分類的 COVID-19 檢測即時檢驗試劑套件市場

  • 鼻咽拭子
  • 口咽拭子
  • 唾液

第12章：按最終用戶分類的 COVID-19 檢測即時檢驗試劑套件市場

  • 診斷中心
  • 居家醫療
  • 醫院

13. 新冠病毒檢測即時檢驗試劑套件市場（依通路分類）

  • 醫院藥房
  • 網路藥房
  • 零售藥房

14. 各地區新冠病毒檢測即時檢驗試劑套件市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 新冠病毒檢測即時檢驗試劑套件市場（按類別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

16. 各國新冠病毒檢測即時檢驗試劑套件市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Abbott Laboratories
    • F. Hoffmann-La Roche Ltd
    • Quidel Corporation
    • Becton, Dickinson and Company
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Siemens Healthineers AG
    • bioMerieux SA
    • LumiraDx UK Ltd
    • SD Biosensor, Inc.
Product Code: MRR-205091A88F53

The COVID-19 Detection PoC Kits Market is projected to grow by USD 6.18 billion at a CAGR of 6.95% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 3.61 billion
Estimated Year [2025] USD 3.86 billion
Forecast Year [2032] USD 6.18 billion
CAGR (%) 6.95%

An authoritative introduction framing how rapid pandemic-era innovation has matured into complex sustainable diagnostic ecosystems across clinical and decentralized settings

The COVID-19 detection proof-of-concept (PoC) kits landscape has evolved from an emergent emergency response into a nuanced and sustained component of diagnostic resilience. In the early phases of the pandemic, rapid assay development and emergency use authorizations prioritized speed over scale, but the intervening years have emphasized robustness, supply continuity, and integration with clinical workflows. This evolution has left the industry with a layered ecosystem of consumables, instruments, and kits designed for diverse settings from centralized laboratories to decentralized point-of-care sites.

As public health priorities shift toward endemic management, stakeholders across clinical testing, research, self-testing, and surveillance applications are demanding solutions that balance sensitivity, usability, and cost efficiency. Detection technologies such as antibody, antigen, and loop-mediated isothermal amplification (LAMP) assays are now assessed not only on analytic performance but on manufacturability, distribution logistics, and regulatory stability. Concurrently, sample collection methods including nasopharyngeal swabs, oropharyngeal swabs, and saliva have prompted iterative improvements in kit design and user instructions to reduce variability and enable wider adoption across diagnostic centers, home care environments, and hospital settings.

The introduction sets the stage for deeper analysis by framing these dynamics within the operational realities of manufacturers, distributors, clinical adopters, and public health authorities. It highlights the central trade-offs organizations face: the need to move beyond emergency deployment models toward sustainable, scalable business and supply chain practices while preserving rapid responsiveness to epidemiological shifts. This balance underpins the subsequent sections, which detail transformative shifts, policy impacts, segmentation nuances, regional patterns, competitive behavior, actionable recommendations, and the methodological approach underpinning the insights presented.

A strategic analysis of the major structural shifts reshaping diagnostic workflows, supply resilience, and technology convergence that redefine proof-of-concept testing

The detection PoC kit environment has been reshaped by several transformative shifts that together redefine how stakeholders approach testing strategy and product development. First, decentralization of diagnostic workflows has become a central imperative. Health systems and private providers increasingly prefer PoC solutions that deliver reliable results outside traditional laboratories, which encourages manufacturers to prioritize user-centric design, simplified sample collection, and integration with digital reporting platforms. Over time, regulatory agencies have adapted pathways for such decentralized tools, which in turn speeds adoption but also raises expectations for post-market surveillance and real-world performance evidence.

Second, supply chain resilience has emerged as a strategic cornerstone. The pandemic exposed single-source dependencies for critical components such as reagents, swabs, and electronic assay modules, prompting investment in diversified sourcing, regional manufacturing capacity, and inventory strategies that buffer against disruption. Third, technology convergence is accelerating: lateral flow immunoassays, antigen detection formats, antibody serology, and LAMP-based nucleic acid amplification are being engineered with complementary strengths to address different clinical and surveillance needs. This technological pluralism enables more tailored diagnostic pathways, but it also complicates procurement and requires new frameworks for comparative evaluation.

Fourth, data integration and interoperability have come to the fore. The utility of PoC testing is amplified when results feed effortlessly into electronic health records, public health dashboards, and patient-facing applications. As a result, software and digital infrastructure partnerships are now integral to product value propositions. Lastly, commercial models have diversified beyond direct sales to include subscription services for reagent replenishment, platform-as-a-service offerings for instrument access, and bundled solutions that combine test kits with telehealth and care navigation. Together, these shifts transform PoC kits from isolated consumables into nodes within broader clinical, logistical, and digital ecosystems.

A rigorous assessment of how tariff-driven trade dynamics are reshaping procurement, manufacturing localization, and cost structures across the diagnostic supply chain

The introduction of heightened tariff measures has a cascading impact across the COVID-19 detection PoC kit value chain, affecting raw materials, finished products, and cross-border distribution strategies. Tariffs alter landed costs for consumables and instruments, prompting manufacturers and procurement teams to reassess sourcing strategies and inventory planning. For manufacturers that rely on specialized components produced abroad, tariffs can incentivize nearshoring and the development of alternate supplier relationships, which in turn can improve long-term resilience but may require near-term capital investment and process qualification.

From a commercial perspective, increased import costs compress margins for suppliers unless offset by price adjustments further downstream. Buyers such as hospitals and diagnostic centers face a tension between cost containment and the need to secure reliable supply, leading some organizations to consolidate suppliers or negotiate longer-term contracts to stabilize unit costs and delivery schedules. Distribution channels including hospital pharmacies, online pharmacies, and retail pharmacies may reconfigure stocking policies and order cycles to mitigate cost volatility and preserve service continuity.

Policy responses to tariff regimes also shape market behavior. Governments may pair tariffs with incentives for domestic manufacturing, offering grants or tax benefits that accelerate regional production capacity. These incentives can create a bifurcated landscape where high-volume standardized products are localized while niche, specialized reagents continue to be imported. The cumulative effect is an industry in transition: operational decisions increasingly prioritize supply chain adaptability and regulatory compliance, and strategic planning must incorporate scenarios that account for tariff-driven cost differentials and their implications for procurement, pricing, and market access.

An integrated segmentation-driven perspective revealing where product design, regulatory evidence, and distribution strategies intersect to maximize adoption and clinical utility

Segmentation analysis provides a framework to understand where innovation, adoption, and commercial opportunity intersect within the PoC kit landscape. When viewed through the lens of product type-consumables, instruments, and kits-distinct operational and commercial considerations emerge. Consumables demand high-volume, repeatable supply and tight quality controls, instruments require capital expenditure justification and lifecycle support, and kits combine reagents and instructions in formats optimized for specific use environments. Each category follows different purchasing cycles and support needs, which in turn affects go-to-market strategies for suppliers.

Application-based segmentation-clinical testing, research, self-testing, and surveillance-highlights differences in performance requirements and user experience. Clinical testing prioritizes validated sensitivity and integration with clinical workflows, research emphasizes flexibility and assay customization, self-testing demands simplicity and robust user instructions to maintain accuracy outside professional settings, and surveillance systems focus on throughput and cost efficiency for population-level monitoring. These application distinctions influence how detection technologies are positioned and validated.

Detection technology segmentation across antibody, antigen, and LAMP modalities reveals divergent use cases and validation pathways. Antibody tests are informative for seroprevalence and past exposure, antigen assays are optimized for rapid detection of active infection with a balance of speed and sensitivity, and LAMP-based approaches offer portable nucleic acid amplification without the complexity of traditional PCR, making them attractive for decentralized settings. Sample type segmentation-nasopharyngeal swab, oropharyngeal swab, and saliva-affects user experience, biosafety considerations, and analytic sensitivity, and choices among these types influence kit design and instructions for use.

End user segmentation into diagnostic centers, home care, and hospitals underscores varying procurement models and technical support expectations. Diagnostic centers often demand batch testing throughput and validated assay comparability, home care prioritizes ease of use and clear interpretability, while hospitals require solutions that integrate into inpatient care pathways with high reliability. Distribution channel segmentation encompassing hospital pharmacy, online pharmacy, and retail pharmacy speaks to accessibility and patient behavior; online channels expand reach and convenience but raise questions about proper storage and guidance, whereas hospital pharmacies anchor medically supervised distribution. Synthesizing these segmentation lenses unveils where product development should target improvements in usability, regulatory evidence, supply planning, and digital integration to meet the specific needs of each stakeholder group.

A nuanced regional synthesis explaining how regulatory frameworks, manufacturing capacity, and healthcare delivery models drive differential adoption of PoC diagnostic solutions

Regional dynamics exert a profound influence on how PoC diagnostic products are developed, regulated, and deployed. In the Americas, heterogeneous regulatory frameworks coexist with sophisticated private healthcare networks and significant purchasing power, which accelerates adoption of advanced point-of-care instruments while also creating pockets of demand for affordable self-testing and surveillance tools. The region's large domestic manufacturing base can be leveraged to mitigate supply chain disruptions, yet disparities in access across urban and rural settings persist and require differentiated distribution approaches.

In Europe, Middle East & Africa, regulatory harmonization efforts and collaborative public health initiatives drive demand for interoperable testing solutions that can be scaled across multiple health systems. The region features a mix of high-volume centralized laboratory capability and emerging decentralized testing programs, particularly where surveillance infrastructure is being strengthened. Local procurement policies and reimbursement models vary, influencing which technologies gain traction and how suppliers structure market entry and partnership strategies.

Asia-Pacific presents a diverse ecosystem ranging from high-capacity manufacturing hubs to rapidly expanding community testing programs. Strong manufacturing ecosystems in several countries support both domestic supply and export-oriented production, and regulatory authorities have shown flexibility in approving innovative diagnostic pathways. Adoption of self-testing formats and digital integration in healthcare delivery is accelerating in urban centers, while rural and remote areas necessitate robust, low-resource-compatible solutions. Across all regions, cross-border collaboration, public-private partnerships, and targeted investment in local production capacity will shape the availability and sustainability of PoC diagnostics, with regional priorities guiding the mix of technologies, sample modalities, and distribution channels deployed.

An evidence-based examination of how strategic partnerships, platform modularity, and total-solution offerings are redefining competitive advantage in diagnostic development

Competitive behavior among firms in the PoC detection space is characterized by rapid product iteration, strategic partnerships, and flexible commercial models. Manufacturers are increasingly pursuing modular platform strategies that allow for quick reconfiguration of assays and reagents to respond to shifts in pathogen biology or market demand. Strategic partnerships with reagent suppliers, contract manufacturers, and software integrators have become central to accelerating time-to-market and scaling distribution capabilities.

Collaboration between diagnostic developers and healthcare providers is another prevalent trend, where early clinical validation and feedback loops inform iterative design improvements. Licensing arrangements and joint ventures enable companies to extend geographic reach without assuming full manufacturing risk, and supply agreements with major institutional buyers help stabilize demand. At the same time, smaller innovators focus on niche applications or unique detection chemistries to differentiate their offerings, often positioning for acquisition or co-development with larger players.

Commercial differentiation increasingly relies on the total solution: assay performance coupled with instrument serviceability, reagent logistics, user training, and digital result management. Firms that invest in post-market support, clear training materials for non-laboratory users, and evidence generation in real-world settings strengthen long-term adoption. Overall, the competitive landscape rewards agility, depth of partnerships, and the ability to provide validated, user-friendly solutions across varied care environments.

Practical strategic recommendations for leaders to build resilient supply chains, enhance user-focused design, and align commercial models with evolving healthcare demands

Industry leaders should pursue a multi-pronged approach that prioritizes supply resilience, user-centered design, and strategic commercialization to capitalize on evolving demand for PoC diagnostics. First, diversify supply chains to reduce single-source dependencies by qualifying alternate suppliers, enabling dual sourcing for critical reagents and components, and investing in regional manufacturing capabilities. This reduces exposure to trade disruptions and tariff volatility while supporting faster response to localized surges in demand.

Second, focus on product usability across varied end users by simplifying sample collection, enhancing instructions for non-professional administration, and embedding fail-safes that reduce user error. Prioritizing formats that accommodate nasopharyngeal, oropharyngeal, and saliva specimens can broaden use cases and improve user acceptance. Third, strengthen digital integration to ensure seamless reporting into clinical records and public health systems, which enhances the value proposition for institutional buyers and supports surveillance objectives.

Fourth, adopt flexible commercial models including reagent replenishment subscriptions and instrument-as-a-service to lower barriers to adoption for smaller facilities. Fifth, engage proactively with regulators and payers to establish evidence generation plans that demonstrate real-world effectiveness in distinct applications such as clinical testing, research, self-testing, and surveillance. Finally, cultivate partnerships across distribution channels including hospital pharmacies, online pharmacies, and retail pharmacies to align stocking practices, training, and supply visibility. These coordinated actions will position organizations to deliver resilient, scalable solutions that meet both clinical and public health needs.

A transparent methodology that blends primary stakeholder interviews and rigorous secondary verification to produce actionable, ethically sourced insights without numeric market estimations

The research methodology underpinning these insights combined structured primary research with systematic secondary analysis to ensure robust and verifiable findings. Primary inputs included semi-structured interviews with stakeholders across the value chain-product developers, procurement officers, clinical users, distribution partners, and regulatory advisors-to capture operational realities, adoption drivers, and unmet needs. These interviews were designed to elicit practical decision criteria and real-world constraints that influence procurement and deployment choices.

Secondary analysis synthesized regulatory guidance, peer-reviewed literature, technical white papers, and publicly available policy documents to contextualize technological performance characteristics and regional regulatory environments. Data triangulation was applied to validate qualitative insights against multiple sources, reducing bias and enhancing reliability. Where appropriate, scenario analysis was employed to evaluate how changes such as tariff adjustments or supply interruptions could affect strategic decisions, focusing on operational levers rather than numerical forecasts.

Limitations include rapidly evolving epidemiological contexts and emerging technological innovations that may shift priorities; therefore, findings emphasize durable strategic considerations and process-oriented recommendations. Ethical considerations were observed in primary research by anonymizing proprietary information and securing consent for participation. The methodology reflects a pragmatic balance between depth of qualitative insight and breadth of secondary evidence to produce actionable guidance for stakeholders across the PoC diagnostic ecosystem.

A succinct conclusion synthesizing strategic imperatives across technology, supply resilience, and user-access considerations to inform sustainable decision-making

In summary, the COVID-19 PoC detection landscape has matured into a complex ecosystem where technology, supply chains, regulation, and user experience interact to determine commercial and public health outcomes. The emphasis has shifted from emergency deployment to sustainable, resilient models that support decentralized testing, robust surveillance, and integration with healthcare delivery systems. Segmentation lenses across product type, application, detection technology, sample type, end user, and distribution channel reveal targeted opportunities for innovation and strategic investment.

Regional dynamics and policy instruments, including trade measures and incentives for local production, will continue to influence where and how solutions are manufactured and distributed. Competitive advantage will accrue to organizations that combine modular product platforms, strategic partnerships, and comprehensive service offerings with clear evidence of real-world performance. Ultimately, the most successful strategies will align technical excellence with pragmatic considerations of supply resilience, user accessibility, and regulatory engagement to ensure diagnostic tools reliably serve both clinical care and public health objectives.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Integration of CRISPR-based diagnostics into portable point-of-care devices for faster COVID-19 detection
  • 5.2. Adoption of multiplex immunoassay lateral flow tests enabling simultaneous detection of multiple respiratory pathogens
  • 5.3. Implementation of smartphone-integrated breath analysis sensors for noninvasive COVID-19 screening at point of care
  • 5.4. Surge in adoption of at-home self-collection antigen kits supported by telemedicine guidance for accurate COVID-19 diagnosis
  • 5.5. Integration of AI-driven image analysis in portable RT-PCR platforms for enhanced result interpretation and reporting

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. COVID-19 Detection PoC Kits Market, by Product Type

  • 8.1. Consumables
  • 8.2. Instruments
  • 8.3. Kits

9. COVID-19 Detection PoC Kits Market, by Application

  • 9.1. Clinical Testing
  • 9.2. Research
  • 9.3. Self Testing
  • 9.4. Surveillance

10. COVID-19 Detection PoC Kits Market, by Detection Technology

  • 10.1. Antibody
  • 10.2. Antigen
  • 10.3. Lamp

11. COVID-19 Detection PoC Kits Market, by Sample Type

  • 11.1. Nasopharyngeal Swab
  • 11.2. Oropharyngeal Swab
  • 11.3. Saliva

12. COVID-19 Detection PoC Kits Market, by End User

  • 12.1. Diagnostic Centers
  • 12.2. Home Care
  • 12.3. Hospitals

13. COVID-19 Detection PoC Kits Market, by Distribution Channel

  • 13.1. Hospital Pharmacy
  • 13.2. Online Pharmacy
  • 13.3. Retail Pharmacy

14. COVID-19 Detection PoC Kits Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. COVID-19 Detection PoC Kits Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. COVID-19 Detection PoC Kits Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. F. Hoffmann-La Roche Ltd
    • 17.3.3. Quidel Corporation
    • 17.3.4. Becton, Dickinson and Company
    • 17.3.5. Thermo Fisher Scientific Inc.
    • 17.3.6. Danaher Corporation
    • 17.3.7. Siemens Healthineers AG
    • 17.3.8. bioMerieux SA
    • 17.3.9. LumiraDx UK Ltd
    • 17.3.10. SD Biosensor, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. COVID-19 DETECTION POC KITS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. COVID-19 DETECTION POC KITS MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. COVID-19 DETECTION POC KITS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CLINICAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CLINICAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CLINICAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CLINICAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY CLINICAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RESEARCH, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RESEARCH, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RESEARCH, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RESEARCH, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SELF TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SELF TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SELF TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SELF TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SELF TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SELF TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SURVEILLANCE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SURVEILLANCE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SURVEILLANCE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SURVEILLANCE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SURVEILLANCE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SURVEILLANCE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIBODY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIBODY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIBODY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIBODY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIBODY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIBODY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIGEN, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIGEN, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIGEN, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIGEN, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIGEN, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ANTIGEN, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY LAMP, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY LAMP, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY LAMP, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY LAMP, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY LAMP, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY LAMP, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY NASOPHARYNGEAL SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY OROPHARYNGEAL SWAB, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SALIVA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SALIVA, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SALIVA, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SALIVA, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SALIVA, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY SALIVA, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITAL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY HOSPITAL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ONLINE PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY ONLINE PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RETAIL PHARMACY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY RETAIL PHARMACY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 133. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 134. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 135. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 136. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 137. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 138. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 139. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 140. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 141. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 142. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 143. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 144. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 145. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 146. AMERICAS COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 150. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 152. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 154. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 156. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 158. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 160. NORTH AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 166. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 168. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 170. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 174. LATIN AMERICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 175. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 176. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 177. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 178. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 179. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 180. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 181. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 190. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 191. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 192. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 193. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 195. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 196. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 197. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 198. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 199. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 200. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 201. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 202. EUROPE COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 204. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 206. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 208. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 210. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 214. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 215. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. MIDDLE EAST COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 218. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 219. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 220. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 221. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 222. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 223. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 224. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 225. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 226. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 227. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 228. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 229. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. AFRICA COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 234. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 235. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 236. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 237. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 238. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 239. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 246. GLOBAL COVID-19 DETECTION POC KITS MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 247. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 250. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 251. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 252. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 253. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 256. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 257. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 258. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 259. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 260. ASEAN COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 261. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 264. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 265. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 267. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 270. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 271. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 272. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 273. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 274. GCC COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 280. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 282. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 286. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. EUROPEAN UNION COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 290. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 291. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 294. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 295. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 296. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 297. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 300. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 301. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. BRICS COVID-19 DETECTION POC KITS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 304. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 305. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 306. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 307. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 308. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 309. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY DETECTION TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 310. G7 COVID-19 DETECTION POC KITS MARKET SIZE, BY DETE